Lead ion is a devastating environmental toxin (Wani, A. L. et al. 2015; Sanders, T. et al. 2009). Analytical methods to detect aqueous lead ions include atomic absorption spectrometry, inductively coupled plasma mass spectrometry, and optical emission spectrometry (Madrid, Y. et al. 1994; Chen, J. et al. 2001; Rapsomanikis, S. et al. 1986; Greda, K. et al. 2016), but these methods are expensive and require trained personnel to operate them. Fluorescent methods are often used to detect lead ions in aqueous and organic solutions due to their operational readiness (Deo, S. et al. 2000; Wan, J. et al. 2017; Dhenadhayalan, N. et al. 2016; Kim, Y. et al. 2015; Li, Z.-h. et al. 2017). However, existing fluorescent probes can optically detect lead ions at a sufficiently high concentration (>10−5 M) because of their low sensitivity. In the case of monolayer-based detection, an even higher concentration of fluorescent probes (>10−4 M) is needed (Ju, H. et al. 2011), which is much higher than the national standard for lead levels in drinking water.
The low sensitivity in fluorescent detection is because of low concentration of metal ions in a given volume of optical excitation. Preconcentration such as extraction can be used to enrich low-concentration metal ions, but it needs more sample and extra operation steps and may lead to contamination (Wu, J. et al. 1997; Mandil, A. et al. 2010; Shi, D. et al. 2016; Goryacheva, I. Y. et al. 2005; Javed, H. et al. 2018). If the probes can be enriched after binding to metal ions, the sensitivity can be enhanced without altering optical illumination and fluorescent detectors (Chen, F. et al. 2015). One way of increasing local concentration of fluorescent probes is to take advantage of size-changeable hydrogels, whose volume can be reduced hundreds or even thousands of times once dehydrated (Wu, Z. L. et al. 2013; Gong, J. et al. 2020).
The idea of volume increase of hydrogels has not been used to enhance metal ion detection when the volume of hydrogel decreases. Agarose gel shrinks more significantly after dehydration than other hydrogels such as polyacrylamide gel and gelatin (Garner, B. W. et al. 2009; Burnham, M. R. et al. 2006; Futscher, M. H. et al. 2017), while agarose lacks active moieties (i.e., amine, carboxyl, or thiol groups) and cannot be modified directly (Ingavle, G. C. et al. 2014). Agarose can be activated to form carboxylated agarose (CA) by oxidizing its primary alcohol groups, and CA can form a stable hydrogel at room temperature (Su, Y. et al. 2013; Forget, A. et al. 2015; Hu, J.-X. et al, 2016; Pierre, G. et al. 2017).
Hydrogels with their biocompatibility and rich surface chemistry are also promising candidates as biosensing platforms (Applewood, D. C. et al. 2011; Savina, I. N. et al. 2016; Meiring, J. E. et al. 2004; Zubtsov, D. A. et al. 2007). The 3D constructs of hydrogels allow immobilization of capturing probes and target analytes with high binding capacity over flat surfaces and thus allow detection of analytes at even lower concentration. However, a major issue associated with hydrogel is that the interlaced networks with randomly oriented pores in the hydrogel made by electrospinning, gas foaming, freeze-thaw and salt templating [Burdick, J. A. et al. 2011; Dadsetan, M. et al. 2008; Dehghani, F. et al. 2011; De France, K. J. et al. 2018; Kumar, A. et al. 2010; Madihally, S. V. et al. 1999) decrease the diffusivity and permeability of molecules, especially biomolecules and large reporters such as nanoparticles (Sandrin, D. et al. 2016; Azpe, E. et al. 2019).
Nanoparticles with unique physical properties have been used as highly sensitive probes to detect biomarkers—antigens, proteins, and nucleic acids—by binding the specific biomarkers to the capturing agents immobilized on nanoparticle surfaces, which alters the physical properties of the nanoparticles. Taking optical property as an example, upon excitation by high energy photons, nanoparticles emit low energy photons as fluorescence emission which is detected after filtering excitation photons. While the sensitivity of nanoparticle-based biomarker detection is relatively high compared to that of organic fluorophores, nanoparticles immobilized on the surface form a monolayer and the number of nanoparticles contributing to fluorescence emission is still low (Lee, H. J. et al. 2008; Lenzi, E. et al. 2019).
The present invention provides a method for detecting a metal ion in an aqueous solution, the method comprising:
The present invention also provides a method for detecting a metal ion in an aqueous solution, the method comprising:
The present invention further provides a method for detecting a metal ion in water, the method comprising:
The present invention further provides a method for detecting a metal ion in water, the method comprising:
The present invention further provides a method for detecting a biomarker in an aqueous solution, the method comprising:
The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawings will be provided by the Office upon request and payment of the necessary fee.
This present invention discloses a signal enhancement mechanism based on size-shrinkable matrix, i.e., size-shrinkable hydrogel, for chemical and biological sensing, in which the signal intensity is amplified by shrinking the size of matrix so that signal can be enhanced by several times. This method can be used for chemical detection and biological detection.
The present inventions provides a method to detect aqueous lead ions at low concentrations with turn-on fluorescence on a size-shrinkable hydrogel (
The prefluorescent probe used herein is a derivative of rhodamine, which is grafted onto the carboxylated agarose (CA) backbone through an amine moiety. Once bound to target metal ions, the molecules undergo a structural change from a spirocyclic lactam to an open-ring amide (Czaplyski, W. L. et al. 2014; Yin, J. et al. 2013), resulting in pink fluorescence emission. The agarose hydrogel shrinks upon dehydration, and the density of fluorescent probes increases in the gel, causing fluorescence signals to be enhanced.
Advantages of the disclose method include low cost, high sensitivity, and non-toxicity. The method is also field deployable and easy to operate.
This present invention also provides a method to enhance the sensitivity of nanoparticle-based protein biomarker detection by exploiting volume reduction of hydrogels upon dehydration. Carboxylated agarose hydrogels with uniaxial channels allow for high diffusivity of biomolecules and fast dehydration. Protein biomarkers, collected from a sample solution and captured on the surface of hydrogel channels, have been detected based on characteristic X-ray fluorescence of nanoparticles, which are modified with ligands of the biomarkers to create a one-to-one correspondence.
Once the nanoparticles bind to the biomarkers captured on the in the hydrogel scaffold, dehydration of the hydrogel scaffold leads to a size reduction over 80 times, and an increase of nanoparticle amount in the interaction volume of primary x-ray beam, leading to the enhanced intensity of X-ray fluorescence imaging. By determining the presence and concentration of the nanoparticles using X-ray fluorescence, the amount of biomarkers can be detected with limits of 2 μg/mL.
The present invention provides a method for detecting a metal ion in an aqueous solution, the method comprising:
In certain embodiments, the method further comprising (5) determining the concentration of the metal ion in the aqueous solution.
In certain embodiments, the metal ion is a Pb2+ ion.
In certain embodiments, the hydrogel is size, e.g. volume, shrinkable.
In certain embodiments, the hydrogel shrinks upon dehydration.
The present invention also provides a method for detecting a metal ion in an aqueous solution, the method comprising:
In certain embodiments, the method further comprising (3a) exposing the dehydrated hydrogel to UV light.
In certain embodiments, the method further comprising (5) determining the concentration of the metal ion in the aqueous solution.
In certain embodiments, the concentration of the metal ion in the aqueous solution and the intensity of the fluorescence of the activated prefluorescent imaging moiety have a linear relationship.
In certain embodiments, the metal ion is a Pb2+ ion.
In certain embodiments, the hydrogel is size shrinkable.
In certain embodiments, the hydrogel shrinks upon dehydration.
In certain embodiments, in step (1), the hydrogel is immersed in the aqueous solution for about 20 to about 60 min.
In certain embodiments, the hydrogel is immersed in the aqueous solution for about 30 min.
In certain embodiments, in step (1), the aqueous solution containing the immersed hydrogel is heated to about 50 to 80° C.
In certain embodiments, the aqueous solution containing the immersed hydrogel is heated to about 60° C.
In certain embodiments, the hydrogel expands upon immersion on the aqueous solution.
In certain embodiments, in step (2), the hydrogel is dehydrated at about 60 to about 90° C.
In certain embodiments, the hydrogel is dehydrated at about 70° C.
In certain embodiments, the hydrogel is dehydrated for about 20 to about 60 min.
In certain embodiments, the hydrogel is dehydrated for about 30 min.
In certain embodiments, the volume of the hydrogel is reduced by about 30 to about 50 times upon dehydration.
In certain embodiments, the volume of the hydrogel is reduced by about 40 times upon dehydration.
In certain embodiments, the intensity of the fluorescence emitted by the activated prefluorescent imaging moiety in the dehydrated hydrogel is about 5 to about 15 times greater relative to the wet hydrogel.
In certain embodiments, the intensity of the fluorescence emitted by the activated prefluorescent imaging moiety in the dehydrated hydrogel is about 10 times greater relative to the wet hydrogel.
In certain embodiments, the hydrogel comprises a modified agarose polymer.
In certain embodiments, the hydrogel comprises a carboxylated agarose polymer. In certain embodiments, the molecular weight of the carboxylated agarose polymer is 50,000-200,000, 50,000-150,000, 75,000-150,000, 80,000-140,000, 100,000-150,000, or about 120,000 amu.
In certain embodiments, each monomer of the carboxylated agarose polymer has the following structure:
In certain embodiments, the latent prefluorescent imaging moiety comprises a modified rhodamine moiety.
In certain embodiments, the modified rhodamine moiety comprises a tris(2-aminoethyl)amino moiety.
In certain embodiments, the latent prefluorescent imaging moiety has the following structure:
In certain embodiments, the activated prefluorescent imaging moiety that is activated upon binding to the metal ion, has the following structure:
The present invention also provides a method for detecting a metal ion in water, the method comprising:
In certain embodiments, the method further comprising (5) determining the concentration of the metal ion in the water.
In certain embodiments, the metal ion is a Pb2+ ion.
In certain embodiments, the hydrogel is size shrinkable.
In certain embodiments, the hydrogel shrinks upon dehydration.
The present invention further provides a method for detecting a metal ion in water, the method comprising:
In certain embodiments, the method further comprising (3a) exposing the dehydrated hydrogel to UV light.
In certain embodiments, the method comprising (5) determining the concentration of the metal ion in the water.
In certain embodiments, the concentration of the metal ion in the water and the intensity of the fluorescence of the activated prefluorescent imaging moiety have a linear relationship.
In certain embodiments, the metal ion is Pb2+ ion.
In certain embodiments, the hydrogel is size shrinkable.
In certain embodiments, the hydrogel shrinks upon dehydration.
In certain embodiments, in step (1), the hydrogel is immersed in the water for about 20 to about 60 min.
In certain embodiments, the hydrogel is immersed in the water for about 30 min.
In certain embodiments, in step (1), the water containing the immersed hydrogel is heated to about 50 to 80° C.
In certain embodiments, the water containing the immersed hydrogel is heated to about 60° C.
In certain embodiments, the hydrogel expands upon immersion on the water.
In certain embodiments, in step (2), the hydrogel is dehydrated at about 60 to about 90° C.
In certain embodiments, the hydrogel is dehydrated at about 70° C.
In certain embodiments, the hydrogel is dehydrated for about 20 to about 60 min.
In certain embodiments, the hydrogel is dehydrated for about 30 min.
In certain embodiments, the volume of the hydrogel is reduced by about 30 to about 50 times upon dehydration.
In certain embodiments, the volume of the hydrogel is reduced by about 40 times upon dehydration.
In certain embodiments, the intensity of the fluorescence emitted by the activated prefluorescent imaging moiety in the dehydrated hydrogel is about 5 to about 15 times greater relative to the wet hydrogel.
In certain embodiments, the intensity of the fluorescence emitted by the activated prefluorescent imaging moiety in the dehydrated hydrogel is about 10 times greater relative to the wet hydrogel.
In certain embodiments, the hydrogel comprises a modified agarose polymer.
In certain embodiments, the hydrogel comprises a carboxylated agarose polymer. In certain embodiments, the molecular weight of the carboxylated agarose polymer is 50,000-200,000, 50,000-150,000, 75,000-150,000, 80,000-140,000, 100,000-150,000, or about 120,000 amu.
In certain embodiments, each monomer of the carboxylated agarose polymer has the following structure:
In certain embodiments, the latent prefluorescent imaging moiety comprises a modified rhodamine moiety.
In certain embodiments, the modified rhodamine moiety comprises a tris(2-aminoethyl)amino moiety.
In certain embodiments, the latent prefluorescent imaging moiety has the following structure:
In certain embodiments, the activated prefluorescent imaging moiety that is activated upon binding to the metal ion, has the following structure:
The present invention further provides a method for detecting a biomarker in an aqueous solution, the method comprising:
In certain embodiments, the method further comprising (6) determining the concentration of the biomarker in the aqueous solution.
In certain embodiments, the first biomarker capturing agent moiety is specific to the biomarker.
In certain embodiments, the second biomarker capturing agent moiety is specific to the biomarker.
In certain embodiments, the first biomarker capturing agent moiety is an antibody.
In certain embodiments, the second biomarker capturing agent moiety is an antibody.
In certain embodiments, the first and second biomarker capturing agent moieties are identical.
In certain embodiments, the first and second biomarker capturing agent moieties different.
In certain embodiments, the biomarker is sandwiched between the first and second biomarker capturing agents. In other embodiments, the first and second biomarker capturing agents bind to different sites on the biomarker.
In certain embodiments, the imaging probe comprises nanoparticles.
In certain embodiments, the imaging probe comprises iron oxide nanoparticles. In other embodiments, the imaging probe comprises polyacrylic-acid-coated iron oxide nanoparticles.
In certain embodiments, the iron oxide nanoparticles are detectable by X-ray fluorescence imaging.
In certain embodiments, the concentration of the biomarker in the aqueous solution and the intensity of the fluorescence of the iron oxide nanoparticles have a linear relationship.
In certain embodiments, the biomarker simultaneously binds to the hydrogel via the first capturing agent moiety and to the imaging probe via the second capturing agent moiety.
In certain embodiments, the hydrogel is size shrinkable.
In certain embodiments, the hydrogel shrinks upon dehydration.
In certain embodiments, the hydrogel comprises a modified agarose polymer.
In certain embodiments, the hydrogel comprises a carboxylated agarose polymer. In certain embodiments, the molecular weight of the carboxylated agarose polymer is 50,000-200,000, 50,000-150,000, 75,000-150,000, 80,000-140,000, 100,000-150,000, or about 120,000 amu.
In certain embodiments, each monomer of the carboxylated agarose polymer has the following structure:
In certain embodiments, the hydrogel comprises vertical channels.
In certain embodiments, the biomarker is an antigen, a protein, or a nucleic acid.
In certain embodiments, the biomarker is a cancer biomarker.
The term “size shrinkable hydrogel” as used herein refers to a hydrogel which shrinks upon removal of water, i.e., dehydration. In general, hydrogels are highly water absorbent and increase in size when immersed in water. Size shrinkable hydrogels are able to shrink upon removal of the water.
The term “prefluorescent imaging moiety” as used herein refers to a moiety which is not capable of fluorescence in its latent state but is capable of fluorescence in its activated state. For example, in the present invention the prefluorescent imaging moiety undergoes a structural change from a spirocyclic lactam (latent state) to an open-ring amide (activated state) upon binding to lead ions.
The term “biomarker” as used herein refers broadly to a molecule found in the body that is a sign of a normal or abnormal process or of a condition or disease. Examples include, but are not limited to, proteins (e.g., an enzyme or receptor), nucleic acids, antibodies, peptides, polypeptides, and antigens. Biomarker detection may confirm the presence of a disease or condition of interest, or identify a subtype of the disease or condition. The biomarker may be present in an aqueous solution containing biological material, such as, but not limited to, blood, serum, urine, sputum, semen, saliva, tissue, fluid, ascites fluid, amniotic fluid, tissue extracts, or cell culture medium. Examples of conditions or disease, include, but are not limited to, cancers, e.g. breast cancer, ovarian cancer, lung cancer, pancreatic cancer, prostate cancer, or melanoma.
The term “biomarker-capturing agent” or “biomarker-capturing moiety” as used herein refers broadly to any agent or moiety that binds to a biomarker. Examples include, but are not limited to, antibodies and fragments thereof, antigens, aptamers, lectins, nucleic acids, and oligosaccharaides. In certain embodiments, the biomarker-capturing agent selectively binds to the biomarker. In certain embodiments, the biomarker-capturing agent or biomarker-capturing moiety is covalently bound to the polymer backbone of the hydrogel.
The term “imaging probe” as used herein refers broadly to any agent that is detectable in an imaging method. In certain embodiments, the imaging probe comprises a biomarker-capturing agent or biomarker-capturing moiety that binds to a biomarker. The detection of the imaging probe allows for a quantitative determination of the concentration of the probe in a given medium, and in turn the concentration of the biomarker. Imaging methods include, but are not limited to, fluorescence imaging and X-ray fluorescence imaging.
Agarose powder was obtained from IBI scientific. Rhodamine 6G (99%) was obtained from Acros Organics. Lead perchlorate trihydrate [crystalline, Pb(ClO4)2], acetonitrile (99%), tris(2-aminoethyl)amine (97%), dichloromethane (CH2Cl2), methanol (>99.8%), and perfluorooctyltrichlorosilane (PFTOS, 97%) were obtained from Alfa Aesar. Tetramethyl-1-piperidinyloxy (98%, TEMPO), sodium bromide (>99.0%, NaBr), sodium hypochlorite solution (10-15%, NaClO), anhydrous sodium sulfate (NaSO4), N-(3-dimethylaminopropyl)-N-ethylcarbodiimide (>97%, EDC), and sodium hydroxide (NaOH) were obtained from Sigma. Polydimethylsiloxane (PDMS) was obtained from Corning. Phosphate-buffered saline (PBS) was obtained from VWR.
Agarose Carboxylation. Agarose was treated with a TEMPO-NaBr—NaClO system to oxidize primary alcohol groups to CA as follows: 1 g of agarose powder was dissolved in 80 mL of water at 90° C. After adjusting the pH to 11 with 1 M aqueous NaOH, the solution was cooled down to room temperature with stirring, and 22 mL of an aqueous solution containing 0.02 g of TEMPO, 0.3 g of NaBr, and 2 mL of NaClO was added dropwise into the agarose solution, and the pH of the solution was maintained at 10-11 by adding 1 M aqueous NaOH. The oxidation reaction was completed in 1.5 h. The solution was precipitated by adding a mixture of 200 mL of isopropyl alcohol and 20 mL of acetone. The precipitate was washed twice with ethanol, and the oxidized agarose was dialyzed for 48 h and lyophilized to remove the solvent.
Grafting Turn-On Fluorescent Probes on Oxidized Agarose. A rhodamine-based turn-on prefluorescent probe was prepared (Ju, H. et al. 2011). A total of 80 mg of oxidized agarose was dissolved in 10 mL of PBS, followed by adding 40 mg of EDC to activate carboxyl groups at 80° C. for 1 h. The modified agarose was mixed with 20 mg of raw agarose to form a hydrogel, which was immersed in deionized water overnight. To graft the turn-on probe, the rinsed hydrogel was mixed with 40 μL of 2 mg/mL turn-on fluorescent probe in acetonitrile at 80° C. After reaction for 1 h, the agarose was rinsed in a mixed acetonitrile and water solution (volume ratio of 20:100) 3 times, followed by centrifugation and evaporation.
Templated Hydrogel Formation. In order to generate hydrogels with defined geometry, a bottomless well made of elastic PDMS was fabricated by using a polyacrylic well (with desired shape and dimension) as the mold. The bottomless well was firmly bonded to plasma-treated glass substrates. The fluorescent probe-immobilized hydrogel at a mass ratio of agarose and water of 1:99 was then injected into the PDMS template and taken out by separating the PDMS template and glass substrate after gelation.
Metal Ion Detection. Aqueous solutions of a variety of metal ions were prepared by dissolving corresponding salts in water with concentrations ranging from 10-1 to 10-7 M. The templated hydrogel was immersed in the solution of each metal ion at 60° C. for 30 min, followed by rinsing with acetonitrile-water (1:10). The hydrogel was dehydrated on a PFTOS-modified hydrophobic glass substrate and dried at 70° C. for 30 min.
The fluorescent images of hydrogels after catching metal ions were taken using an Olympus BX51 fluorescence microscope. The fluorescence intensity at each pixel of an image was derived by using ImageJ software. The zeta potential change of the hydrogel before and after modification was measured with a NANO ZS ZEN3600 zeta potential analyzer (Malvern Instruments). Fourier transform infrared (FTIR) spectra of hydrogels were collected with a spectrometer (Bruker Vertex 70) combined with a Hyperion 1000 microscope.
Once bound to a target cation, the molecule undergoes a structural change from a spirocyclic lactam to an open-ring amide, which results in fluorescence in pink. The zeta potential of the aqueous solution of pristine agarose was nearly neutral (−2 mV), and oxidized agarose is negatively charged (−16.8 mV) due to formation of carboxyls. FTIR spectra indicated the vibrational peaks of carboxyl groups of oxidized agarose at the wavenumbers of 1400 and 1600 cm-1 (
Fluorescence Emission upon Lead Binding
Disuccinimidyl suberate (DSS), biotin-PEG2-amine and avidin were from Thermofisher. Phosphate buffered saline (PBS) was from VWR and tween 20 was from Acros. Bovine serum albumin (BSA), dimethyl sulfoxide (DMSO, 99%) and perfluorooctyltrichlorosilane (PFTOS, 97%) were from AlfaAesar. The following chemicals were from Sigma-Aldrich: tetramethyl-1-piperidinyloxy (TEMPO, 98%), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (EDC, 97%), N-Hydroxysuccinimide (NHS), (3-aminopropyl) triethoxysilane (APTES), sodium hydroxide (NaOH), sodium bromide (NaBr, 99.0%), sodium hypochlorite solution (NaClO, 10-15%), and iron oxide nanoparticles (25 nm diameter, 5 mg/mL). Agarose powder was from IBI Scientific.
Chemical Modification of Agarose—Agarose was treated with TEMPO-NaBr—NaClO to oxidize the primary alcohol groups to carboxylated agarose (CA) as follows. 1 g of agarose powder was dissolved in 80 mL of water at 90° C. After adjusting pH to 11 with 1M of aqueous NaOH, the solution was cooled to room temperature while stirring. 22 mL of an aqueous solution containing 0.02 g TEMPO, 0.3 g NaBr, and 2 mL NaClO was then added dropwise into the agarose solution, and the pH of the solution was maintained at 10-11 by adding 1 M NaOH solution. The oxidation reaction was completed in 1.5 hours. The solution was precipitated by adding a mixture of 200 mL of isopropyl alcohol and 20 mL of acetone. The precipitate (i.e., oxidized agarose) was washed twice with ethanol, dialyzed for 48 hours and lyophilized to remove solvent.
Carboxylation of hydrogel scaffold—Freeze-thaw method was used to make hydrogel scaffolds with vertical channels as follows. 0.05 g of carboxylated agarose (CA) and 0.05 g of agarose were dissolved in 10 mL of water at 100° C., followed by gelation at room temperature. The hydrogel was made into a cylinder of 1.5 cm in diameter, cut as 2.5 cm in length and placed on a copper block, which sits at the top of a foam box. The freezing process started when liquid nitrogen was filled in the box, creating a uniaxial thermal gradient. The samples were allowed to freeze for 10 min and removed from the copper block to thaw at room temperature, followed by cutting to thin slabs of 1.5 mm thick.
Biotin-conjugated iron oxide nanoparticles—0.2 mL of aqueous solution of iron oxide nanoparticles was mixed with 5 mL of alcoholic solution of APTES (0.2% by weight) for 2 hours under stirring. After removing excess chemicals by centrifuge, nanoparticles were suspended in 2 mL of DMSO containing 4 mg of DSS as the crosslinker for 1 hour at 37° C. The solution was added into a 2 mL aqueous solution of biotin-PEG2-amine (containing 10 mg of biotin-PEG2-amine) for 2 hours. Biotin modified nanoparticles were then rinsed water and centrifuged for three times. Fluorescent images of nanoparticles were taken with an Olympus BX51 fluorescence microscope. Scanning electron microscopy (SEM) images were taken by high-resolution field emission scanning electron microscope Hitachi S-4800. Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectra were collected with a Thermo Scientific Nicolet iS10 FTIR spectrometer.
Protein detection—The schematic detection processing is shown in Figure. Avidin was dissolved in the sterile water at concentrations ranging from 0.2 g/mL to 2 mg/mL. The carboxylated agarose was immersed in the avidin solution for an hour at 37° C. and then rinsed by using 0.1% tween 20 and water three times. In order to block carboxyl groups on hydrogel, the carboxylated agarose was then immersed in an aqueous solution of BSA (0.5% by weight) for 1 hour at 37° C., followed by rinsing with tween 20 solution and water. In order to image the avidin modified hydrogel, iron oxide nanoparticles with biotin labels were added into the scaffold for 30 min. The unbounded nanoparticles were removed from tween 20 solutions using a magnet. The scaffold was then placed on a PFTOS modified glass slide and dehydrated in an oven at 50° C.
X-ray fluorescence detection—A Mini-X X-ray tube (Amptek, Bedford Mass.) operating at 40 kV and 15 A was used to generate primary X-rays. The tube was fitted with a brass collimator to reduce the beam size to 1 mm in diameter. An X-ray spectrometer (Amptek X-123) with Si—PIN photodiode was used to collect X-ray fluorescence (XRF) signals in reflection modes, where the tube and the detector were fixed on a mounting plate with an angle of 45° between them. The tube-sample distance and sample detector distance are kept at 3 and 2 cm respectively, and the setup was enclosed in a lead containing acrylic chamber.
The hydrogel was made into a cylinder of 1.5 cm in diameter, cut as 2.5 cm in length and placed on a copper block, which sits at the top of a foam box (
The diffusivity of a molecule in the hydrogel was derived by observing the distance of the front of a fluorescently labeled dye with time while partially immersing the hydrogel in the solution of fluorescent molecules.
The iron oxide nanoparticles were modified to have biotin at the outmost.
The detection of protein antibodies was performed on channel hydrogels as specified in the materials section. The area of the XRF peak of iron is used to derive the amount of iron oxide nanoparticles attached to hydrogel gel.
In the next experiment to detect avidin, the thickness of hydrogel is set at 1.5 mm and a magnet is used to remove unbounded nanoparticles prior to hydrogel dehydration.
The volume reduction of hydrogels upon dehydration was used to enhance the sensitivity of turn-on fluorescence detection of lead ions in water. The rhodamine-derived fluorescent probes grafted on CA hydrogel showed excellent selectivity to lead ions and superior turn-on fluorescence upon binding lead ions. The dehydration of hydrogel lead to a volume reduction of more than 40 times and can effectively increase fluorescence emission to 10 times higher after capturing lead ions at a concentration of 10−7 M. The enhancement is at such a degree that the turn-on fluorescence upon lead ion binding was easily seen with naked eyes. Given its low cost, straightforwardness, easy operation, and high sensitivity, this volume-changing hydrogel can be used to detect lead ions in drinking water.
The volume reduction of hydrogels upon dehydration was also employed to enhance the sensitivity of X-ray fluorescence detection of biomarkers. A method is disclosed to enhance the sensitivity of nanoparticle-based protein detection using size-shrinkable hydrogels, in which X-ray fluorescence nanoparticles are captured on a hydrogel scaffold that has aligned channel structures (
The area density or concentration of nanoparticles is increased by use of size-reducible hydrogels, whose volume can be reduced tens or even hundreds of times upon dehydration (Wu, Z. L., et al. 2013; Kudo, K. et al. 2014). This approach was used to increase the sensitivity of metal ion detection by using organic fluorophore; however, extending this technique to nanoparticle probes for biomolecule detection remains challenging because the diffusion resistances of biomolecules and nanoparticles into porous constructs are significant. A temperature gradient controlled ice crystallization was developed to produce porous scaffolds with vertically aligned channels that extend the full length of hydrogel thin film (Stokols, S. et al. 2006; Hua, M. et al. 2021). Carboxylated agarose hydrogel scaffolds, composed of uniaxial channels extending through their entire length, allow high diffusivity of biomolecules and fast dehydration.
All of the U.S. patents and U.S. and PCT published patent applications cited herein are hereby incorporated by reference.
The foregoing written specification is considered to be sufficient to enable one skilled in the art to practice the invention. The present invention is not to be limited in scope by examples provided, since the examples are intended as a single illustration of one aspect of the invention and other functionally equivalent embodiments are within the scope of the invention. Various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description and fall within the scope of the appended claims. The advantages and objects of the invention are not necessarily encompassed by each embodiment of the invention.
This application claims the benefit of priority to U.S. Provisional Patent Application No. 63/173,002, filed Apr. 9, 2021.
Number | Date | Country | |
---|---|---|---|
63173002 | Apr 2021 | US |